Episode Details

Back to Episodes
Pharmaceutical Executive Daily: FDA Approves Pasatru

Pharmaceutical Executive Daily: FDA Approves Pasatru

Published 2 months, 4 weeks ago
Description
A partnership roundup covers deals from IntraGel Therapeutics/UroGen Pharma and Lupin/Tenpoint Therapeutics, FDA approves Regeneron's Pasatru for fibrodysplasia ossificans progressiva, and RELEX's Rohit Tripathi discusses reshoring pharma manufacturing.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us